McKenna Horstmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
McKenna Horstmann has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Assata Kokayi
Mayo Clinic
1 shared publication - Jane Q. Yap
Department of Quantitative Health Sciences Mayo Clinic Jacksonville Florida USA
1 shared publication - Karen M. Meagher
Mayo Clinic
1 shared publication - Kelly E. Ormond
Department of Genetics Stanford University School of Medicine Stanford California USA
1 shared publication - Kiran Musunuru
Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
1 shared publication - Kirsten A. Riggan
Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 23 February 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (6) , 11-25
Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare
Despite considerable scientific progress and the evolution of regulatory pathways to ensure safety and efficacy, US healthcare continues to see increasing health disparities. This suggests that clinical translation in of itself cannot be the only measure of its own success, especially when the most marginalized patients, are neglected in the development and implementation of medical innovations. This raises the question of whether a system that is narrowly focused on technical achievement can meet the moral obligations of medicine and public health. We argue that traditional technocratic standards are failing to integrate normative considerations into biomedical translation. What is needed is a translational domain that moves beyond safety and efficacy toward anticipating how proposed technologies will be effective in society as it exists. We propose an additional metric of success: translational justice.
- 23 February 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (6) , 11-25
Open AccessBuilding Better Medicine: Translational Justice and the Quest for Equity in US Healthcare
Despite considerable scientific progress and the evolution of regulatory pathways to ensure safety and efficacy, US healthcare continues to see increasing health disparities. This suggests that clinical translation in of itself cannot be the only measure of its own success, especially when the most marginalized patients, are neglected in the development and implementation of medical innovations. This raises the question of whether a system that is narrowly focused on technical achievement can meet the moral obligations of medicine and public health. We argue that traditional technocratic standards are failing to integrate normative considerations into biomedical translation. What is needed is a translational domain that moves beyond safety and efficacy toward anticipating how proposed technologies will be effective in society as it exists. We propose an additional metric of success: translational justice.